Industries > Pharma > Global Antibacterial Drugs Market 2019-2029

Global Antibacterial Drugs Market 2019-2029

Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others

PUBLISHED: 25 April 2019
PAGES: 297
PRODUCT CODE: PHA0377
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The global antibacterial drugs market is estimated to have reach $43bn in 2018 and is expected to grow at a CAGR of 2% in the first half of the forecast period. The Cephalosporins submarket held 28% of the global antibacterial drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 297-page report you will receive 144 tables and 105 figures– all unavailable elsewhere.

The 297-page report provides clear detailed insight into the global antibacterial drugs market analysis. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Antibacterial Drugs Market forecasts from 2019-2029

Revenue forecasts for the 6 leading submarkets from 2019-2029:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others

Revenue forecasts for the 43 leading marketed antibacterial drugs from 2019-2029:
Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam
Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil
Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin
Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin
Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax
Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin

Revenue forecasts for the leading regional markets forecasted in this report are the following:
• North America
• Europe
• Asia-Pacific
• RoW

Each regional market is further segmented by the 6 leading submarkets.

Revenue forecasts for the leading national markets forecasted in this report are the following:
• The US
• Japan
• Italy
• France
• The UK
• Spain
• Germany
• China
• India
• Brazil
• Russia
• South Korea

Global Antibacterial Drugs Market 2019-2029

This report discusses the selected leading companies:
• Adenium Biotech ApS,
• Allecra Therapeutics GmbH
• AstraZeneca
• Bayer
• BioVersys AG
• Eli Lilly
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Pfizer

Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market

Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development – see progress in this industry, finding technological, clinical and commercial outlooks and opportunities

• Key Questions Answered by this Report:
• Gain forecasts from 2019 to 2029 for the overall world market and its leading submarkets, as well as those for prominent national markets.
• Explore the regulatory landscape for leading regional and national markets, as well as expected developments for the period 2019-2029.
• Identify drug development trends that will affect market participants from 2019 to 2029. This report contains SWOT and STEP analysis for the forecast period.
• See discussions of companies developing, manufacturing and marketing antibiotics, exploring products, technologies, R&D, partnerships, M&A and outlooks.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Antibacterial Drugs Market. You find data, trends and predictions.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2019-2029


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories